Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices

Closed Solicitation Posted

This opportunity was awarded. See its 6 award notices in the notice history.

Solicitation number
75N93021R00019
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases seeks proposals for the development of radiation and nuclear medical countermeasures and bio-dosimetry devices. Specifically, proposals are sought for advancing one lead medical countermeasure demonstrated effective in an animal model of radiation exposure, as well as bio-dosimetry assays. Proposals will be evaluated using standard FAR evaluation criteria and are due by April 15, 2022. An amendment provides answers to fifteen questions from potential offerors regarding the subject solicitation.

There is no set-aside designation for this procurement. Performance will occur within the United States under anticipated cost-reimbursement contracts. The amendment does not specify NAICS, PSC, incumbents, budget values, or timelines. No restrictions exist on the use of foreign or Chinese subcontractors to perform the work.

Notice text

AMENDMENT No.1

This amendment is to provide answers to questions received regarding the subject solicitation.  See attachment BAA 21R00019_AMENDMENT 1.

Files

File Type Posted
BAA 21R00019_ AMENDMENT 1.pdf PDF

Notice history

9 of 12 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors